Snapchat is courting pharma marketers with a new ad format designed to support the disclosure needs of branded prescription drug campaigns. Advertisers on Snapchat, a social media platform on which ...

WuXi AppTec has been caught in the crosshairs of ongoing scrutiny over China’s booming biotechnology industry since 2024, when the Biosecure Act, which aims to keep taxpayer dollars away from “foreign ...

As Alnylam’s Amvuttra sales disappointed, revenue from BridgeBio’s rival transthyretin amyloidosis (ATTR) drug Attruby came in above analysts’ expectations. | Despite their divergent second-quarter ...

Nearly three decades after its failed bid for FDA approval, the cardiovascular drug levosimendan is still struggling to ...

Abbott has enlisted telenovela star Gabriela Spanic to push the message that getting screened for colon cancer doesn’t have ...

ITM’s application rested on data from the phase 3 Compete trial in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). These malignancies arise in a specialized group of neurons ...

Bristol Myers Squibb has laid out plans for a $2.3 billion manufacturing facility in Houston, set for completion in 2030. The plant will cover 600,000 square feet and employ nearly 500 people.

Scholar Rock has shed Novo Nordisk’s troubled Catalent facility as a contract manufacturer in its FDA refiling for apitegromab, a candidate for spinal muscular atrophy. The Cambridge, ...

Inizio’s Engage arm is widening its global medical information offerings with its new ‘Connected Insights’ platform. The new expansion merges regional expertise in the Asia-Pacific market, enhanced ...

Injected weight loss drugs remain favored over newer oral treatments by a significant margin, with Eli Lilly’s Zepbound ...

Novo Nordisk has made Omnicom the agency of record for U.S. media buying, ending the drugmaker’s six-year partnership with ...